Operating Lease, Right-of-Use Asset of Aquestive Therapeutics, Inc. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Aquestive Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • Aquestive Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $4,769,000, a 10% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Aquestive Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $4,769,000 -$541,000 -10% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $4,911,000 -$524,000 -9.6% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $5,049,000 -$393,000 -7.2% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $5,182,000 -$375,000 -6.7% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $5,310,000 -$359,000 -6.3% 30 Sep 2024 10-Q 04 Nov 2024 2024 Q3
Q2 2024 $5,435,000 -$343,000 -5.9% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $5,442,000 -$442,000 -7.5% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $5,557,000 +$346,000 +6.6% 31 Dec 2023 10-K 05 Mar 2025 2024 FY
Q3 2023 $5,669,000 +$3,575,000 +171% 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 $5,778,000 +$3,464,000 +150% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 $5,884,000 +$3,360,000 +133% 31 Mar 2023 10-Q 02 May 2023 2023 Q1
Q4 2022 $5,211,000 +$2,486,000 +91% 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q3 2022 $2,094,000 -$823,000 -28% 30 Sep 2022 10-Q 01 Nov 2022 2022 Q3
Q2 2022 $2,314,000 -$788,000 -25% 30 Jun 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 $2,524,000 -$753,000 -23% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $2,725,000 -$723,000 -21% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $2,917,000 -$692,000 -19% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 $3,102,000 -$662,000 -18% 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 $3,277,000 -$635,000 -16% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 $3,448,000 +$3,448,000 31 Dec 2020 10-K 08 Mar 2022 2021 FY
Q3 2020 $3,609,000 30 Sep 2020 10-Q 04 Nov 2020 2020 Q3
Q2 2020 $3,764,000 30 Jun 2020 10-Q 04 Aug 2020 2020 Q2
Q1 2020 $3,912,000 31 Mar 2020 10-Q 05 May 2020 2020 Q1
Q4 2019 $0 31 Dec 2019 10-K 09 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.